Synthon Hispania, S.L.

The drug is intended for the treatment of advanced renal cell carcinoma (kidney cancer) in cases where a previous course of systemic therapy has not been effective.

Dosage form: tablets, film-coated

ATC: L01EK01

The drug is intended for the treatment of advanced renal cell carcinoma (kidney cancer) in cases where a previous course of systemic therapy has not been effective.

Dosage form: tablets, film-coated

ATC: L01EK01

The drug is used for the treatment of advanced prostate cancer in combination with other therapy (LHRH analogues) or surgical castration.

Dosage form: tablets, film-coated

ATC: L02BB03

The drug is prescribed for the treatment of patients with locally advanced prostate cancer at high risk of disease progression. It may be used as monotherapy or as an adjuvant therapy following surgical removal of the gland or radiotherapy. It is also indicated for patients with locally advanced non-metastatic prostate cancer who are not candidates for surgical intervention.

Dosage form: tablets, film-coated

ATC: L02BB03

The drug is used for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, as well as for the relief of pain and inflammation in acute gouty arthritis. It is also used for short-term pain relief following dental procedures.

Dosage form: tablets, film-coated

ATC: M01AH05

The drug is used for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, as well as for the relief of pain and inflammation in acute gouty arthritis. It is also used for short-term pain relief following dental surgery.

Dosage form: tablets, film-coated

ATC: M01AH05

The drug is used for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, as well as for the relief of pain and inflammation in acute gouty arthritis. It is also used for short-term pain relief following dental procedures.

Dosage form: tablets, film-coated

ATC: M01AH05

The drug is used for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, as well as for the relief of pain and inflammation in acute gouty arthritis. It is also used for short-term pain relief following dental procedures.

Dosage form: tablets, film-coated

ATC: M01AH05

The drug is used to prevent bone damage (pathological fractures and bone lesions requiring surgical intervention or radiotherapy) in patients with breast cancer and bone metastases.

Dosage form: tablets, film-coated

ATC: M05BA06

The drug is intended for the treatment of osteoporosis in postmenopausal women who are at an increased risk of fractures.

Dosage form: tablets, film-coated

ATC: M05BA06

The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced forms after recurrence, or neoadjuvant therapy).

Dosage form: tablets, film-coated

ATC: L02BG04

The drug is prescribed for hormonal therapy in postmenopausal women with various forms of breast cancer (at early stages, in advanced cancer, after recurrence, or as preparation for surgery).

Dosage form: tablets, film-coated

ATC: L02BG04

The drug is used for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder (with or without agoraphobia), social phobias, generalized anxiety disorder, and post-traumatic stress disorder.

Dosage form: tablets, film-coated

ATC: N06AB05

The drug is used for the treatment of advanced prostate cancer in combination with other hormonal therapy or surgical castration.

Dosage form: tablets, film-coated

ATC: L02BB03

The drug is intended for the treatment of patients with locally advanced prostate cancer at high risk of disease progression. It can be used as monotherapy or as an adjuvant therapy following surgical intervention or radiotherapy. It is also indicated for patients for whom surgical treatment is not suitable.

Dosage form: tablets, film-coated

ATC: L02BB03